+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Kidney Dialysis Equipment and Supplies - Global Market Trajectory & Analytics

  • ID: 338852
  • Report
  • May 2021
  • Region: Global
  • 587 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • JMS Co. Ltd.
  • Kawasumi Laboratories
  • Medical Components, Inc.
  • Nikkiso Group
  • Nipro Corporation

Global Kidney Dialysis Equipment and Supplies Market to Reach $27.5 Billion by 2027


Amid the COVID-19 crisis, the global market for Kidney Dialysis Equipment and Supplies estimated at US$19.1 Billion in the year 2020, is projected to reach a revised size of US$27.5 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Hemodialysis, one of the segments analyzed in the report, is projected to record a 5% CAGR and reach US$19.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peritoneal Dialysis segment is readjusted to a revised 5.7% CAGR for the next 7-year period.







The U.S. Market is Estimated at $4.8 Billion, While China is Forecast to Grow at 7% CAGR


The Kidney Dialysis Equipment and Supplies market in the U.S. is estimated at US$4.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

CRRT Systems Segment to Record 7% CAGR


In the global CRRT Systems segment, USA, Canada, Japan, China and Europe will drive the 6.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.8 Billion by the year 2027, while Latin America will expand at a 8.1% CAGR through the analysis period.

Select Competitors (Total 89 Featured) -

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Fresenius Medical Care North America
  • JMS Co. Ltd.
  • Kawasumi Laboratories
  • Medical Components, Inc.
  • Nikkiso Group
  • Nipro Corporation
  • Rockwell Medical Technologies, Inc.
  • Teleflex Medical
  • Terumo Corporation
  • Toray Medical Co. Ltd.
Frequently Asked Questions about the Global Market for Kidney Dialysis Equipment and Supplies

What is the estimated value of the Global Market for Kidney Dialysis Equipment and Supplies?

The Global Market for Kidney Dialysis Equipment and Supplies was estimated to be valued at $19.1 Billion in 2020.

What is the growth rate of the Global Market for Kidney Dialysis Equipment and Supplies?

The growth rate of the Global Market for Kidney Dialysis Equipment and Supplies is 5.3%, with an estimated value of $27.5 Billion by 2027.

What is the forecasted size of the Global Market for Kidney Dialysis Equipment and Supplies?

The Global Market for Kidney Dialysis Equipment and Supplies is estimated to be worth $27.5 Billion by 2027.

Who are the key companies in the Global Market for Kidney Dialysis Equipment and Supplies?

Key companies in the Global Market for Kidney Dialysis Equipment and Supplies include Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Fresenius Medical Care North America, JMS Co. Ltd., Kawasumi Laboratories, Medical Components, Inc. and Nipro Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • JMS Co. Ltd.
  • Kawasumi Laboratories
  • Medical Components, Inc.
  • Nikkiso Group
  • Nipro Corporation
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • COVID-19 Disease Leads to Notable Surge in Kidney Failure Rates
  • Dialysis Facilities Step Up Efforts to Protect Kidney Failure Patients from COVID-19
  • Spike in COVID-19-related Kidney Failure Cases amidst Shortage of Dialysis Machines
  • Kidney Dialysis Equipment & Supplies: An Introductory Prelude
  • Rising Prevalence of Kidney Diseases: Cornerstone for Present & Future Growth
  • Exhibit 1: ESRD Prevalence Worldwide: Number of Treated ESRD Patients Per Million Population in Select Countries for 2019
  • Exhibit 2: Global Dialysis Patient Population Breakdown by Geographic Region/Country (2019 and 2024)
  • Exhibit 3: Global Population of Kidney Disease Patients Undergoing Treatment by Type of Modality (2019 and 2022P): Percentage Breakdown of Patients Undergoing Dialysis Therapy and Kidney Transplantation
  • Outlook
  • Continuous Renal Replacement Therapy Market Set for a Steady Growth
  • Hemodialysis Continue to Dominate the Dialysis Equipment Market
  • Peritoneal Dialysis Segment to Report Improved Growth
  • Demand for Dialysis Disposables Remains Strong
  • Developed Regions Account for a Major Share
  • Exhibit 4: Developed Regions Dominate the Global Dialysis Equipment & Supplies Market: Percentage Breakdown of Revenues for Developed Regions and Developing Regions (2020 & 2027P)
  • Developing Markets: Hot Spots for Future Growth
  • Competition
  • Kidney Dialysis Equipment and Supplies Competitor Market Share Scenario Worldwide (in %): 2019
  • Hemodialysis (Type) Global Competitor Market Share Positioning for 2019
  • Peritoneal Dialysis (Type) Market Share Breakdown of Key Players: 2019
  • Leading Players in the Global Continuous Renal Replacement Market: 2019
  • Product Recalls Remain Key Concern for Participants
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • Growing Number of ICU Patients Spurs the Need for CRRT
  • Technological Advancements to Bolster CRRT Market Growth
  • Development of New Hemofilters to Propel Market Expansion
  • Development of CRRT System for Pediatric Patients
  • Technological Innovations Pave the Way Forward
  • Hemodialysis Remains the Major Modality for Dialysis Treatment
  • Exhibit 5: Global Dialysis Patient Population Distribution by Modality for Select Countries (2016): Percentage Breakdown of Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients
  • Exhibit 6: Global Population of ESRD Patients Undergoing Therapy by Type of Treatment (2019): Percentage Breakdown of Patients Receiving Hemodialysis, Kidney Transplants, and Peritoneal Dialysis
  • Nocturnal Hemodialysis: A Promising Technique for Dialysis
  • Home Hemodialysis: A Niche Albeit High Potential Market
  • Exhibit 7: World Dialysis Clinics Market by Region (2019): Percentage Breakdown of Patients Treated by Type of Operator
  • Exhibit 8: Global Dialysis Market by Region: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings for 2019
  • Affinity for Home-Based Care Strengthens Prospects for PD Market
  • Exhibit 9: HD-PD Treatment Cost Ratio for China, India, Mexico, UK, and US
  • New Machines Designed to Address Requirement for Pediatric Dialysis
  • High-Flux Dialyzers Gain Traction
  • Synthetic Dialyzers Emerge As Mainstay Tools
  • Increasing Penetration of Single-Use Dialyzers
  • Rise in Lifestyle Diseases Fuels Incidence of Renal Diseases
  • Exhibit 10: World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Exhibit 11: Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030, and 2045
  • Exhibit 12: World Diabetes Prevalence (2000 - 2019)
  • Exhibit 13: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2019 and 2045
  • Exhibit 14: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
  • Exhibit 15: Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
  • Burgeoning Global Geriatric Populace, Longer Life Expectancy to Sustain Demand for Renal Care Procedures
  • Exhibit 16: Global Life Expectancy at Age 60 and 80 Years: 2010-2015; 2020-2025; and 2045-2050
  • Exhibit 17: Global Population Statistics for 65+ Age Group (Male & Female) by Region: 2019 and 2050
  • Exhibit 18: Number of Persons Aged 65 Years and Above, By Region: 2019 And 2050
  • Improving Healthcare Expenditure to Boost Dialysis Infrastructure Development and Market Access in Developing Countries
  • Exhibit 19: Healthcare Expenditure as a % of GDP by Region for 2019
  • DIALYSIS: A REVIEW
  • Dialysis: A Historical Perspective
  • Kidney Disorders Addressed Through Dialysis
  • Dialysis Methods
  • Hemodialysis (HD)
  • Peritoneal Dialysis (PD)

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

UNITED STATES
  • Market Overview
  • Exhibit 20: US Dialysis Patient Population by Modality (2019)
  • Ageing Demographics Steers Growth in the Market
  • Exhibit 21: Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030
  • Exhibit 22: North American Aging Population by Age Group: 1975-2050
  • Surging Diabetic Population Drives the Need for Dialysis
  • Exhibit 23: Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
  • Exhibit 24: Number of Diabetics by Gender (in %) in the US: 2019
  • Exhibit 25: Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group for 2019
  • Exhibit 26: Diabetes Prevalence by Ethnicity: 2019
  • Home Dialysis Continues to Exhibit Steady Increase
  • Exhibit 27: US Dialysis Market Type: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings (2019)
  • Exhibit 28: US Dialysis Market Type: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings (2019)
  • Wider Prevalence of Dialysis Clinics Steers Market Prospects
  • Exhibit 29: Leading Providers of Dialysis Services in the US Ranked by Number of Patients for 2019
  • Single Use Dialyzers Gain Traction
  • Technological Innovations Aid Market Expansion
  • Dialysis Industry Facing High Costs and Mortality
  • Reimbursement Scenario for Dialysis Treatments for ESRD Patients
  • Competitive Scenario
  • Exhibit 30: Leading Players in the US Dialysis Equipment Market: Percentage Breakdown of Sales Revenues by Competitor for 2019

CANADA
  • Growing Cases of Diabetes Drives Market Growth
  • Exhibit 31: Diabetes Statistics in Canada (2019): Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s)
  • Home Dialysis Gains Impetus

JAPAN
  • Market Overview
  • Exhibit 32: Dialysis Patient Population by Modality (in %) in Japan (2019)

CHINA
  • Market Overview
  • High Prevalence of Diabetes Offers Growth Opportunities for Market
  • Exhibit 33: Diabetes Statistics in China (2019): Number of Adults with Diabetes (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (in ‘000s), and Number of Diabetes-Related Deaths (in ‘000s)
  • Ongoing Expansion in the Domestic Healthcare Sector Bodes Well

EUROPE
  • Market Overview
  • Exhibit 34: Dialysis Patient Population by Modality for Select European Countries: 2019
  • Exhibit 35: Europe Dialysis Market Breakdown of Patients Receiving Dialysis Treatment (in %) in In-Centre and Home Settings for 2019
  • Exhibit 36: European Dialysis Clinics Market: Breakdown of Number of Patients Receiving Treatment (in %) by Operator Type (2019)
  • Diabetes Prevalence in Europe
  • Exhibit 37: Diabetes and Population Statistics in Europe (2019, 2030 & 2045)

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC
  • Market Overview
  • Exhibit 38: Diabetes and Population Statistics in South East Asia (2019, 2030 & 2045)
  • Exhibit 39: Diabetes and Population Statistics in Western Pacific (2019, 2030 & 2045)
  • Hemodialysis Leads the Market
  • Exhibit 40: Dialysis Patient Population by Modality (in %) in Select Asian Countries (2019)
  • Exhibit 41: Asia-Pacific Dialysis Market Breakdown of Patients Receiving Dialysis Treatment (in %) in In-Centre and Home Settings: 2019

AUSTRALIA

INDIA
  • Growing Awareness & Increased Access to Dialysis Care Steers Momentum
  • Exhibit 42: Dialysis Patient Population by Modality in India (2019)
  • Increasing Healthcare Expenditure Augments Market Prospects

SOUTH KOREA

REST OF ASIA-PACIFIC
  • Focus on Select Regional Markets

LATIN AMERICA
  • Key Statistical Findings
  • Exhibit 43: Dialysis Patient Population by Modality for Brazil and Mexico (2019)
  • Exhibit 44: Latin American Dialysis Market: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings for 2019

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION
  • Total Companies Profiled: 89
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Fresenius Medical Care North America
  • JMS Co. Ltd.
  • Kawasumi Laboratories
  • Medical Components, Inc.
  • Nikkiso Group
  • Nipro Corporation
  • Rockwell Medical Technologies, Inc.
  • Teleflex Medical
  • Terumo Corporation
  • Toray Medical Co. Ltd.
Note: Product cover images may vary from those shown